Redenlab ataxia experience

box-icon

Sites

40

box-icon

Patients

500

box-icon

Languages

14

box-icon

Clinical trials

10+

box-icon

Natural history studies

10+

    Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      Redenlab’s CEO, Adam Vogel, co-wrote "The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia"...
        Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination difficulties. SCA1...

          A new study published in the European Journal of Human Genetics provides the first systematic analysis of speech and language difficulties in individuals with KIF1A-associated neurological disorder (KAND).

            Redenlab is looking for a versatile Machine Learning Deployment Engineer with a strong background in both model operationalization and fine-tuning/training to help scale our ML services.

              Redenlab is looking for an experienced executive assistant and bookkeeper to assist in managing our day-to-day business activities accounting and finance requirements.